b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29508243</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>11</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>04</Month>\n            <Day>11</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1179-1934</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>32</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>03</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>CNS drugs</Title>\n                <ISOAbbreviation>CNS Drugs</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>189-196</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40263-018-0504-x</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">In the treatment of pediatric epilepsy, there is a critical demand for effective and safe therapeutic options to address patients\' unmet clinical needs. Eslicarbazepine acetate is a novel once-daily antiepileptic drug and a third-generation single enantiomer member of the dibenzazepine family.</AbstractText>\n                <AbstractText Label="OBJECTIVE">The objective of this study was to evaluate the efficacy and safety of eslicarbazepine acetate as add-on treatment for focal-onset seizures in pediatric patients using meta-analytical techniques.</AbstractText>\n                <AbstractText Label="METHODS">Randomized, placebo-controlled, single- or double-blinded add-on trials of eslicarbazepine acetate in patients\xe2\x80\x89&lt;\xe2\x80\x8918\xc2\xa0years of age with focal-onset seizures uncontrolled by concomitant stable antiepileptic drug regimens were identified through a systematic literature search. The assessed outcomes included the mean relative change and\xe2\x80\x89\xe2\x89\xa5\xe2\x80\x8950% reduction in the baseline seizure frequency, the incidence of treatment withdrawal, serious adverse events, and treatment-emergent adverse events. Risk ratio and weighted mean difference with 95% confidence intervals were estimated for dichotomous/continuous outcomes.</AbstractText>\n                <AbstractText Label="RESULTS">Two trials were included involving 386 participants (age range 2-18\xc2\xa0years), 217 for eslicarbazepine acetate and 169 for placebo groups, respectively. At the dosage of 30\xc2\xa0mg/kg/day, eslicarbazepine acetate-treated patients had a significantly greater reduction in baseline seizure frequency (weighted mean difference -\xe2\x80\x8921.67, 95% confidence interval -\xe2\x80\x8940.87 to -\xe2\x80\x892.46; p\xe2\x80\x89=\xe2\x80\x890.027) and 58 patients (44.6%) were seizure responders compared with 27 controls (29.7%) [risk ratio 1.48, 95% confidence interval 0.99-2.20; p\xe2\x80\x89=\xe2\x80\x890.055]. There were no differences in treatment withdrawal (risk ratio 1.24, 95% confidence interval 0.65-2.37; p\xe2\x80\x89=\xe2\x80\x890.513), serious adverse events (risk ratio 1.40, 95% confidence interval 0.69-2.86; p\xe2\x80\x89=\xe2\x80\x890.350), and treatment-emergent adverse events (risk ratio 1.07, 95% confidence interval 0.94-1.22; p\xe2\x80\x89=\xe2\x80\x890.313).</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Adjunctive eslicarbazepine acetate could be an effective well-tolerated option in children and adolescents with focal-onset seizures uncontrolled by one or more concomitant anti-epileptic drugs.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Lattanzi</LastName>\n                    <ForeName>Simona</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy. alfierelattanzisimona@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Brigo</LastName>\n                    <ForeName>Francesco</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Neurology, &quot;Franz Tappeiner&quot; Hospital, Merano, BZ, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Grillo</LastName>\n                    <ForeName>Elisabetta</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Department Eisai s.r.l., San Donato Milanese, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cagnetti</LastName>\n                    <ForeName>Claudia</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Verrotti</LastName>\n                    <ForeName>Alberto</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics, University of L\'Aquila, L\'Aquila, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zaccara</LastName>\n                    <ForeName>Gaetano</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit of Neurology, Department of Medicine, USL Centro Toscana Health Authority, Firenze, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Silvestrini</LastName>\n                    <ForeName>Mauro</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017418">Meta-Analysis</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>New Zealand</Country>\n            <MedlineTA>CNS Drugs</MedlineTA>\n            <NlmUniqueID>9431220</NlmUniqueID>\n            <ISSNLinking>1172-7047</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D003984">Dibenzazepines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>BEA68ZVB2K</RegistryNumber>\n                <NameOfSubstance UI="C416835">eslicarbazepine acetate</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003984" MajorTopicYN="N">Dibenzazepines</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004828" MajorTopicYN="N">Epilepsies, Partial</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010372" MajorTopicYN="Y">Pediatrics</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>3</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>3</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29508243</ArticleId>\n            <ArticleId IdType="doi">10.1007/s40263-018-0504-x</ArticleId>\n            <ArticleId IdType="pii">10.1007/s40263-018-0504-x</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>N Engl J Med. 2017 Oct 26;377(17 ):1639-1647</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29069568</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol. 2018 Apr;265(4):733-740</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29159466</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 2013 May;54 Suppl 2:19-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23646966</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12111919</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Neurosci Ther. 2017 Dec;23 (12 ):961-972</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29030894</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 2006 Mar;47(3):626-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16529631</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2015;29(10):847-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26400189</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Seizure. 2015 Apr;27:71-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25891931</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Saf. 2017 Dec;40(12 ):1231-1240</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28752473</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Neurol Scand. 2018 Jan;137(1):29-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28741673</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2006 Feb 11;367(9509):499-524</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16473127</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cerebrovasc Dis. 2017;43(5-6):207-213</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28241129</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12958120</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Saf. 2012 Jul 1;35(7):519-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22702637</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2013 Jun;27(6):435-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23673774</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann N Y Acad Sci. 2013 Jul;1291:56-68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23859801</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 1988 Mar-Apr;29(2):103-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3258233</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Pharmacol. 2008 Aug;48(8):966-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18508949</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2014 Jul 22;83(4):339-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24944265</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2010 May;24(5):399-430</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20192278</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 1993 May-Jun;34(3):453-68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8504780</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurol Neurochir Pol. 2017 May - Jun;51(3):266-269</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28385340</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Seizure. 2008 Jul;17(5):405-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18262442</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Neurol. 2017 May;70:7-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28242084</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19621072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2016 Apr 5;86(14 ):1344-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26944275</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol. 2017 Aug;264(8):1697-1704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28492970</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'